Fig. 3From: Safety analysis of new medications in clinical trials: a simulation study to assess the differences between cause-specific and subdistribution frameworks in the presence of competing eventsClassification of results of competing risk analyses in cause-specific and subdistribution settings into outcome categoriesBack to article page